These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15680911)

  • 21. Netherton syndrome in two Japanese siblings with a novel mutation in the SPINK5 gene: immunohistochemical studies of LEKTI and other epidermal molecules.
    Shimomura Y; Sato N; Kariya N; Takatsuka S; Ito M
    Br J Dermatol; 2005 Nov; 153(5):1026-30. PubMed ID: 16225619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases.
    Raghunath M; Tontsidou L; Oji V; Aufenvenne K; Schürmeyer-Horst F; Jayakumar A; Ständer H; Smolle J; Clayman GL; Traupe H
    J Invest Dermatol; 2004 Sep; 123(3):474-83. PubMed ID: 15304086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Processing, secretion, and anti-HIV-1 activity of IL-16 with or without a signal peptide in CD4+ T cells.
    Zhou P; Devadas K; Tewari D; Jegorow A; Notkins AL
    J Immunol; 1999 Jul; 163(2):906-12. PubMed ID: 10395686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of human torsinA and its dystonia-associated mutant form.
    Liu Z; Zolkiewska A; Zolkiewski M
    Biochem J; 2003 Aug; 374(Pt 1):117-22. PubMed ID: 12780349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secretion of cytoplasmic and nuclear proteins from animal cells using novel secretion modules.
    Farrell PJ; Behie LA; Iatrou K
    Proteins; 2000 Oct; 41(1):144-53. PubMed ID: 10944401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia.
    Pidasheva S; Canaff L; Simonds WF; Marx SJ; Hendy GN
    Hum Mol Genet; 2005 Jun; 14(12):1679-90. PubMed ID: 15879434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis.
    Fortugno P; Bresciani A; Paolini C; Pazzagli C; El Hachem M; D'Alessio M; Zambruno G
    J Invest Dermatol; 2011 Nov; 131(11):2223-32. PubMed ID: 21697885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pre- and pro-sequence of thaumatin on the secretion by Pichia pastoris.
    Ide N; Masuda T; Kitabatake N
    Biochem Biophys Res Commun; 2007 Nov; 363(3):708-14. PubMed ID: 17897626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requirement for the COOH-terminal pro-sequence in the translocation of aqualysin I across the cytoplasmic membrane in Escherichia coli.
    Kim DW; Matsuzawa H
    Biochem Biophys Res Commun; 2000 Oct; 277(1):216-20. PubMed ID: 11027666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor.
    Meyer-Hoffert U; Wu Z; Schröder JM
    PLoS One; 2009; 4(2):e4372. PubMed ID: 19190773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The N-terminal signal peptide of the murine cyclophilin mCyP-S1 is required in vivo for ER localization.
    Schumacher A; Westermann B; Osborn M; Nordheim A
    Eur J Cell Biol; 1994 Apr; 63(2):182-91. PubMed ID: 8082644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses.
    Kido H; Beppu Y; Imamura Y; Chen Y; Murakami M; Oba K; Towatari T
    Biopolymers; 1999; 51(1):79-86. PubMed ID: 10380355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LEKTI demonstrable by immunohistochemistry of the skin: a potential diagnostic skin test for Netherton syndrome.
    Ong C; O'Toole EA; Ghali L; Malone M; Smith VV; Callard R; Harper JI
    Br J Dermatol; 2004 Dec; 151(6):1253-7. PubMed ID: 15606522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accurate disulfide formation in Escherichia coli: overexpression and characterization of the first domain (HF6478) of the multiple Kazal-type inhibitor LEKTI.
    Lauber T; Marx UC; Schulz A; Kreutzmann P; Rösch P; Hoffmann S
    Protein Expr Purif; 2001 Jun; 22(1):108-12. PubMed ID: 11388807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum.
    Ishida-Yamamoto A; Deraison C; Bonnart C; Bitoun E; Robinson R; O'Brien TJ; Wakamatsu K; Ohtsubo S; Takahashi H; Hashimoto Y; Dopping-Hepenstal PJ; McGrath JA; Iizuka H; Richard G; Hovnanian A
    J Invest Dermatol; 2005 Feb; 124(2):360-6. PubMed ID: 15675955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the carboxyl terminal stop transfer sequence of UGT1A6 membrane protein in ER targeting and translocation of upstream lumenal domain.
    Ouzzine M; Barré L; Netter P; Magdalou J; Fournel-Gigleux S
    FEBS Lett; 2006 Apr; 580(8):1953-8. PubMed ID: 16529747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topology and endoplasmic reticulum retention signals of the lysosomal storage disease-related membrane protein CLN6.
    Heine C; Quitsch A; Storch S; Martin Y; Lonka L; Lehesjoki AE; Mole SE; Braulke T
    Mol Membr Biol; 2007; 24(1):74-87. PubMed ID: 17453415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI.
    Bennett K; Callard R; Heywood W; Harper J; Jayakumar A; Clayman GL; Di WL; Mills K
    J Proteome Res; 2010 Aug; 9(8):4289-94. PubMed ID: 20533828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein.
    Komatsu N; Saijoh K; Otsuki N; Kishi T; Micheal IP; Obiezu CV; Borgono CA; Takehara K; Jayakumar A; Wu HK; Clayman GL; Diamandis EP
    Clin Chim Acta; 2007 Feb; 377(1-2):228-36. PubMed ID: 17140555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secretion of glycosylation site mutants can be rescued by the signal/pro sequence of tissue plasminogen activator.
    Köhne C; Johnson A; Tom S; Peers DH; Gehant RL; Hotaling TA; Brousseau D; Ryll T; Fox JA; Chamow SM; Berman PW
    J Cell Biochem; 1999 Dec; 75(3):446-61. PubMed ID: 10536368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.